Cytomegalovirus pneumonia in transplant recipients

Michael G. Ison, Jay A. Fishman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

54 Scopus citations


The incidence of CMV pneumonia has been reduced by routine antiviral prophylaxis in susceptible populations. Many of the complications of this infection are caused by indirect effects of the virus, including acute and chronic graft rejection, GVHD, and superinfection by other viruses, bacteria, and fungi. Distinction must be made between viral secretion and invasion. Invasive procedures are often required for the optimal management of such infections. The use of sensitive and quantitative assays has greatly improved the outcomes of CMV infection.

Original languageEnglish (US)
Pages (from-to)691-705
Number of pages15
JournalClinics in Chest Medicine
Issue number4
StatePublished - Dec 2005

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Cytomegalovirus pneumonia in transplant recipients'. Together they form a unique fingerprint.

Cite this